Oaktree Capital Group Holdings GP, LLC - 25 Nov 2024 SCHEDULE 13G Report for BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI)

Filing Manager
Oaktree Capital Group Holdings GP, LLC
Reporting Manager
Oaktree Capital Group Holdings GP, LLC
Security
BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
BTAI
Shares outstanding
52,386,058 shares
Disclosed Ownership
2,724,075 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
18 Dec 2024, 20:19:12 UTC
Date of event
25 Nov 2024
Next filing
15 May 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Oaktree Fund Advisors, LLC 1.6% 822,944 0 822,944 /s/ Henry Orren Henry Orren / Authorized Signatory
OAKTREE CAPITAL MANAGEMENT LP 3.6% 1,901,131 0 1,901,131 /s/ Henry Orren Henry Orren / Authorized Signatory
Oaktree Capital Group Holdings GP, LLC 5.2% 2,724,075 0 2,724,075 /s/ Henry Orren Henry Orren / Authorized Signatory
Oaktree Capital Holdings, LLC 5.2% 2,724,075 0 2,724,075 /s/ Henry Orren Henry Orren / Authorized Signatory